Selective serotonin reuptake inhibitor discontinuation syndrome: A review

@article{Tamam2002SelectiveSR,
  title={Selective serotonin reuptake inhibitor discontinuation syndrome: A review},
  author={Lut Tamam and Nurgul Ozpoyraz},
  journal={Advances in Therapy},
  year={2002},
  volume={19},
  pages={17-26}
}
Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed in the treatment of depression and anxiety, as well as obsessive-compulsive, eating, and impulse-control disorders. Paralleling their widespread use has been an increase in adverse-effect reports not noted during short-term efficacy studies. Significant among these adverse effects is SSRI discontinuation syndrome, which follows the interruption of extended treatment or a reduction in drug dosage and entails somatic and… Expand
Pharmacotherapy of Mood Disorders and Treatment Discontinuation
TLDR
The antidepressant discontinuation syndrome is characterised by the time-locked emergence of new, clearly defined and quantifiable signs and symptoms that ensue on stopping or reducing the dose of an antidepressant, and meets the criteria for a withdrawal syndrome. Expand
Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case series
  • M. Fornaro
  • Medicine, Psychology
  • Annals of general psychiatry
  • 2011
TLDR
Agomelatine may have a role in the management of OCD, essentially due to its anxiolytic 5-hydroxytryptamine (HT)2C blockade action, while melatonin (MT)1 and MT2 modulation might contribute to circadian rhythm restoration if impaired. Expand
Encephalopathy Associated with Psychotropic Drug Therapy
TLDR
In this chapter, the author provides a comprehensive overview of the abovementioned adverse effects affecting the CNS function associated with psychotropic pharmacotherapy. Expand
8 Encephalopathy Associated with Psychotropic Drug Therapy
All therapeutic interventions are double-edged swords with benefits and adverse effects, and pharmacotherapy is not an exception. Shortly after the introduction of conventional antipsychotic drugsExpand
Medication dependence and anxiety
TLDR
Pharmacological therapy for anxiety should be prescribed and managed so as to minimize any existing risk, while aiming to restore the patient to wellness in terms of symptoms and function. Expand
Dapoxetine: a new option in the medical management of premature ejaculation
  • C. McMahon
  • Medicine
  • Therapeutic advances in urology
  • 2012
TLDR
Dapoxetine, as the first drug developed for PE, is an effective and safe treatment for PE and represents a major advance in sexual medicine. Expand
Antidepressant-Antianxiety Agents
TLDR
Psychotropic drugs are now the most widely used psychotropic drugs, and even more in general medicine than in psychiatry, and their origins in the 1950s were aimed specifically at a relatively complex group of depressive disorders prior to consolidation and broad acceptance of the concept “major depressive disorder. Expand
Dapoxetine for premature ejaculation
  • C. McMahon
  • Medicine
  • Expert opinion on pharmacotherapy
  • 2010
TLDR
Dapoxetine, as the first drug developed for PE, is an effective and safe treatment for PE and represents a major advance in sexual medicine. Expand
Efficacy of Dapoxetine in the Treatment of Premature Ejaculation
  • C. McMahon
  • Medicine
  • Clinical medicine insights. Reproductive health
  • 2011
TLDR
Dapoxetine, as the first drug developed for PE, is an effective and safe treatment for PE and represents a major advance in sexual medicine. Expand
Recent advances in bipolar disorder pharmacotherapy: focus on bipolar depression and rapid cycling
This article reviews recent advances in the evidence base for effective pharmacotherapy in bipolar disorder. We focus first on bipolar depression, since this pole of the illness forms the bulk of theExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 55 REFERENCES
Discontinuation Syndromes with Selective Serotonin Reuptake Inhibitors
Selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors (SSRIs), like the tricyclic antidepressants and monoamine oxidase inhibitors, are associated with a well recognised syndromeExpand
The SSRI discontinuation syndrome
  • P. Haddad
  • Medicine
  • Journal of psychopharmacology
  • 1998
A characteristic selective serotonin reuptake inhibitor (SSRI) discontinuation syndrome appears to exist. It is usually mild, commences within 1 week of stopping treatment, resolves spontaneouslyExpand
Antidepressant discontinuation: a review of the literature.
TLDR
It is important to directly question patients about new symptoms that occur during antidepressant discontinuation to optimally manage treatment discontinuation. Expand
Interruption of selective serotonin reuptake inhibitor treatment
TLDR
Abrupt interruption of SSRI treatment can result in a syndrome characterised by specific physical and psychological symptoms, and placebo substitution for paroxetine was associated with increases in the number and severity of adverse events following the second missed dose, and increases in functional impairment at five days. Expand
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial
TLDR
Abrupt interruption of antidepressant therapy for 5-8 days was associated with the emergence of new somatic and psychological symptoms in patients treated with paroxetine and to a lesser degree sertraline, with few symptoms seen with fluoxetines. Expand
Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel.
TLDR
Experts have hypothesized that since some symptoms associated with paroxetine withdrawal are similar to those of tricyclic antidepressant discontinuation, they may be caused by cholinergic rebound, which is a factor in SRI discontinuation phenomena. Expand
Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel.
TLDR
A group of experts convened in Phoenix, Arizona, to develop a clear description or definition of the SRI discontinuation syndrome, which is distinctly different from the classic withdrawal syndrome associated with alcohol and barbiturates and may be minimized by slowly tapering antidepressant therapy. Expand
Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria.
OBJECTIVE To establish specific criteria by which selective serotonin reuptake inhibitor (SSRI) discontinuation syndrome may be identified. DATA SOURCES MEDLINE and PSYCHLIT databases were searchedExpand
The abrupt discontinuation of fluvoxamine in patients with panic disorder.
TLDR
Abrupt fluvoxamine discontinuation is associated with a characteristic syndrome in many patients, and the most frequent symptoms reported were dizziness/incoordination, headaches, nausea, and irritability. Expand
Serotonin reuptake inhibitor withdrawal.
TLDR
Reports of withdrawal symptoms in a retrospective chart review of 352 patients treated in an outpatient clinic with the nonselective serotonin reuptake inhibitor clomipramine or with one of the selective SSRIs, fluoxetine, fluvoxamine, paroxettine, or sertraline suggest a role has been suggested for serotonin in coordinating sensory and autonomic function with motor activity. Expand
...
1
2
3
4
5
...